SecBot SecBot
Insider Cluster (3 insiders) ·Filed Aug 17, 2026

RYTM

RHYTHM PHARMACEUTICALS, INC.
NEUTRAL
Impact 4/10
Horizonimmediate Processed3mo ago
Insider cluster: 3 insiders, $9.8M total
Actionable Insight • Neutral

The cluster is dominated by a single large sale from the EVP of North America that is mechanically linked to option exercises, a classic cashless exercise pattern that does not convey negative information. The total dollar value is trivial relative to the $8.0B market cap (0.12%). Per academic literature, cluster sales are not predictive of negative returns, and the strong Q2 beat and raised pipeline outlook provide a positive fundamental backdrop. No bearish read-through is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

IMCIVREE

▲ Bullish Named in this insider cluster
Impact
Not rated
Phase
Not stated
Time to market
Not stated
Next catalyst
None dated

Fresh Drug Report

This drug report is still fresh. Subscribe to read its impact, phase, next catalyst and thesis.

Subscribe for Full Access

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$115.25
T+0 close · Aug 17, 2026 · via day close
Latest settled
−1.13%
T+60 · $113.95
Vs SPY
+0.91%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 18 $115.25entry
  2. T+1 · 3mo ago +0.42%α +0.21% · $115.73
  3. T+5 · 3mo ago −1.65%α −1.45% · $113.35
  4. T+20 · 2mo ago −13.93%α −12.94% · $99.20
  5. T+60 · 6d ago −1.13%α +0.91% · $113.95

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Rhythm Pharmaceuticals executives sold a total of $9.77M in open-market stock within a week of the company's strong Q2 2026 earnings beat. The sales are concentrated in the EVP of North America (Jennifer Kayden Lee, $8.9M) and follow a period of significant stock appreciation, suggesting profit-taking and option exercise monetization rather than a bearish signal on fundamentals.

Key Financial Metrics

Direction
selling
Total Value
$9.8M
Insiders
3

Key Facts

  • Three insiders sold a total of $9.77M in open-market stock from Aug 12-13, 2026.
  • EVP Jennifer Kayden Lee accounted for $8.9M of the total, selling 75,834 shares at ~$117.38.
  • All sales occurred 8-9 days after the company reported a Q2 2026 revenue beat ($71.3M vs $67.7M consensus) and a 12% EPS beat.
  • The $9.77M in sales represents approximately 0.12% of RYTM's $8.0B market cap.
  • Lee's sales were accompanied by the exercise of 56,601 stock options at $0-$24.29 strike prices, indicating a cashless exercise-and-sell pattern.
  • CTO Joseph Shulman and CSO Alastair Garfield also sold shares totaling $608K and $913K respectively.

Financial Impact

$9.77M in insider sales, or 0.12% of market cap

insider ownershipdilution

Risk Factors

  • Insider selling could accelerate if the stock continues to appreciate, creating overhead supply.
  • The concentration of sales in the North America commercial head may signal a personal liquidity event rather than a company-specific concern.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RYTM-1787004110005

Track record

26 reports on RYTM

Performance horizon

9 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +32.06% at T+60 after the May 1, 2026 report. 11 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bullish 5/10 Entry $107.48 Now $115.02 +7.02% settles Nov 24
  2. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $110.68 to $112.16 Now $115.02 +3.92% ▲ +1.34% +2.25% vs SPY
  3. Nov 4, 202612d ago Press Release Bullish 5/10 Entry $110.68 to $112.16 Now $115.02 +3.92% ▲ +1.34% +2.25% vs SPY
  4. Nov 3, 202613d ago 8-K Bullish 6/10 No price data
  5. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $86.44 to $113.95 Now $115.02 +33.06% ▲ +31.83% +32.41% vs SPY
  6. Nov 2, 202613d ago Press Release Neutral 5/10 Entry $86.44 to $113.95 Now $115.02 +33.06% ▲ +31.83% +32.41% vs SPY
  7. Oct 13, 20264w ago Press Release Bullish 6/10 Entry $86.71 to $88.62 Now $115.02 +32.65% ▲ +2.20% +1.75% vs SPY
  8. Oct 13, 20264w ago SC 13G Neutral 3/10 Entry $86.61 to $90.20 Now $115.02 +32.80% ▲ +4.14% +5.30% vs SPY
  9. Sep 14, 20269w ago 144 Bearish 5/10 Entry $96.77 to $99.27 Now $115.02 −18.86% ▼ −2.58% −0.47% vs SPY
  10. Aug 17, 202613w ago Insider Cluster Bearish 6/10 Entry $115.25 to $113.35 Now $115.02 +0.20% ▲ +1.65% +1.45% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (12h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 17, 2026